Log in

APTX Apotex Health Corp. TSX · Canada

Apotex Health (APTX) news

Apotex Health Corp. is a public biotech or pharmaceutical company listed on TSX under the ticker APTX, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Apotex Health news

We have not published a story on Apotex Health yet. When there is news, it will appear here.

Questions about Apotex Health

What is the ticker symbol of Apotex Health?

Apotex Health Corp. trades under the ticker APTX on TSX.

Where is Apotex Health listed?

Apotex Health Corp. is listed on TSX. Our directory also records these other listings: NEO:APTX.

Which country or territory is Apotex Health listed under?

Our directory records Apotex Health Corp. under Canada.

What does Apotex Health do?

Our directory classifies Apotex Health Corp. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Apotex Health?

The ISIN recorded for Apotex Health Corp. is CA03772D1015.

Does aibio.space cover Apotex Health?

aibio.space lists Apotex Health Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Apotex Health?

Companies in our directory listed in the same country and business area as Apotex Health: Nurexone Biologic, EGF Theramed Health, RepliCel Life Sciences, ABATTIS BIOCEUTICALS CORP, Mindbio Therapeutics, Simply Solventless Concentrates.

Investor discussion: Apotex Health

Members talk about Apotex Health (APTX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSX:APTX on TradingView.

Listing details

Apotex Health Corp. is a public biotech or pharmaceutical company listed on TSX under the ticker APTX, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Apotex Health Corp.
Ticker
APTX
Listing
TSX
Country or territory
Canada
Business scope
Pharmaceuticals: Major
ISIN
CA03772D1015
Other listed symbols
NEO:APTX
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.